Journals
RSS Feed Readers

Filter by Tag:   Date:
Journals
25
Aug

Helsinn Therapeutics Begins Global Pivotal Phase III Clinical Program to Evaluate Anamorel

Posted by: Admin

Helsinn Therapeutics Initiates Global Pivotal Phase III Clinical Program to Evaluate Anamorelin in Non-Small Cell Lung Cancer-Associated Anorexia/Cachexia Ghrelin...Read More

30
Jun

NVP-AUY922 Is a Novel Cancer Drug to Treat Squamous Cell Carcinoma

Posted by: Admin

Novartis Develops NVP-AUY922, an Inhibitor of Heat-Shock Protein 90 to Treat Squamous Cell Carcinoma ...Read More

14
Jun

Zarebczan et al. Report Research on Carcinoid Tumor

Posted by: Admin

  Research on Carcinoid Tumors Reported By Zarebczan et al. at University of Wisconsin Recent research report,” Hesperetin,...Read More

08
Jun

Tosedostat In Acute Myeloid Leukemia: Phase 2 Study Shows Promise

Posted by: Admin

Tosedostat Shows Encouraging Results In Phase 2 Study For Acute Myeloid Leukemia In Elderly Patients Cell Therapeutics released phase 2 study results...Read More

07
Jun

Merck’s Ridaforolimus extends survival in Sarcoma Patients

Posted by: Admin

Merck’s Ridaforolimus Achieves Primary endpoint in phase III SUCEED Trial Merck’s ridaforolimus improved progression-free survival (PFS) compared...Read More

03
Jun

Pfizer Seeks Permission for Oncology drug Axitinib from EU

Posted by: Admin

Pfizer Recently Announced Seeking Permission for Axitinib the Novel Oncology Candidate ...Read More

03
May

Zytiga approved by US FDA for Advanced Prostate Cancer

Posted by: Admin

Abiraterone acetate (brand name: Zytiga) approved by US FDA for Advanced Prostate Cancer ...Read More

25
Apr

Nectar's Next-generation topoisomerase I inhibitor, NKTR-102 given Orphan Drug Status

Posted by: Admin

Nektar's oncology drug candidate NKTR-102 given orphan drug status NKTR-102 is an investigational...Read More

25
Apr

Pro-Pharma's Novel Compound Targets Galectin Proteins

Posted by: Admin

Pro-Pharma’s DAVANAT, a Carbohydrate Polymer Targets Galectin Proteins Over-expressed by Cancer Cells ...Read More

25
Apr

Patients of Brain Tumor can now live longer, Scientist discovers a Molecule

Posted by: Admin

 Patients of Brain Tumor can now live longer, Scientist discovers a new molecule, Nutlin 3a ...Read More

Journals are primarily meant for Medical practitioners and healthcare service providers to find out what’s new and happening in the medical world. Latest scientific breakthroughs, research, events and conferences will all be there for you. This section of HealthLine 24x7 will ensure that you are constantly updated on the latest discovery, innovation and experiment. You can browse through the journal content available on HealthLine 24x7 either date wise or category wise. The current categories available are Cardiology, Neurology and Oncology. The few journals available on Healthline24x7 currently are, “Alzheimer and Heart Disease Share a Common Gene according To the Latest Research,” “A Ray of Hope for Patients with Severe Aortic Stenosis,” “Vioxx and Heart Attack-The Mystery Solved,” “Repairing Damaged Hearts, Naturally,” “To Get A Mammogram Or Not.”